Page 7
CAMPUS NEWS
PROVOST AWARDED HONORARY DEGREE
ON MONDAY 30 June 2008, the Provost, Dr John Hegarty, was awarded a Doctor of Laws from Queen’s University, Belfast in acknowledgement of his services to higher education.
FORMER PROVOST WATTS RECEIVES DISTINGUISHED CAREER AWARD
DR WILLIAM WATTS M.A., Sc.D., F.T.C.D., M.R.I.A. (1952), Provost from 1981 to 1991, was honoured in June 2008 with the presentation of the Distinguished Career Award (2008) from the American Quaternary Association (AMQUA) at its biennial meeting, held this year at State College, Pennsylvania. This is AMQUA’s most prestigious award, given for research carried out in North America.
William has recently published his memoirs, which record his life and times from student to Provost over forty years, as well as his research career in Quaternary Science (the Quaternary Period covers the last two million years). The book gives a feeling and flavour of the society of the College during those times and records major incidents and events.
William Watts, Provost Trinity College Dublin, a Memoir is published by Lilliput/Hinds.
(Photo captioned: Dr William Watts receives the Distinguished Career Award from Dr Eric Grimm, President of AMQUA.)
(Photo captioned: Trinity College Dublin Innovation Award winners Dr Steven Collins and Mr Hugh Reynolds with the Provost, Dr John Hegarty.)
TCD Innovation Award Showcases University and Industry Links
THE TRINITY COLLEGE Dublin Innovation Award for 2007 was awarded to Dr Steven Collins and Mr Hugh Reynolds for their work on establishing Havok, a games industry software company that was recently sold to Intel for €76M.
Havok is the premier provider of interactive software and services for digital media creators in the games and movie industries. Its products have been used to drive special effects in movies such as Poseidon, The Matrix, Troy, Kingdom of Heaven and Charlie and the Chocolate Factory. Havok has offices in San Francisco, Calcutta, Munich and Tokyo.
New Test for Early Detection of Alzheimer’s Disease developed by TCD Researchers
A new test for the early detection of Alzheimer’s disease has been developed by the TCD Chair of Psychiatry, Professor Harald Hempel. The study shows that the biological marker in the brain called p-tau 231 is a significant predictor of cognitive decline and conversion in the transition from the clinically at risk syndrome Mild Cognitive Impairment (MCI) to Alzheimer’s disease.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68